| Gut microbiome differences between metformin‐and liraglutide‐treated T2 DM subjects Z Wang, S Saha, S Van Horn, E Thomas, C Traini, G Sathe, DK Rajpal, ... Endocrinology, Diabetes & Metabolism 1 (1), e00009, 2018 | 66 | 2018 |
| The promise of the anti-idiotype concept T Kieber-Emmons, B Monzavi-Karbassi, A Pashov, S Saha, R Murali, ... Frontiers in Oncology 2, 196, 2012 | 39 | 2012 |
| Carbohydrate-mimetic peptides for pan anti-tumor responses T Kieber-Emmons, S Saha, A Pashov, B Monzavi-Karbassi, R Murali Frontiers in Immunology 5, 97762, 2014 | 31 | 2014 |
| Human microbial metabolites as a source of new drugs S Saha, DK Rajpal, JR Brown Drug discovery today 21 (4), 692-698, 2016 | 29 | 2016 |
| Expanding the drug discovery space with predicted metabolite–target interactions E Nuzzo, A., Saha, S., Berg Communications Biology 4 (288), 2021 | 13 | 2021 |
| Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses SS Lan Y, Yeung T, Huang H Journal for Immunotherapy of Cancer 10 (7), 2022 | 10 | 2022 |
| Defining the recognition elements of Lewis Y-reactive antibodies S Saha, A Pashov, ER Siegel, R Murali, T Kieber-Emmons Plos one 9 (8), e104208, 2014 | 9 | 2014 |
| Anticarbohydrate antibodies: from molecular basis to clinical application P Kosma, S Müller-Loennies Springer Science & Business Media, 2011 | 8 | 2011 |
| The potential role of solvation in antibody recognition of the Lewis Y antigen S Saha, R Murali, A Pashov, T Kieber-Emmons Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 34 (5), 295-302, 2015 | 5 | 2015 |
| M9657 is a bispecific tumor-targeted anti-CD137 agonist that induces MSLN-dependent antitumor immunity without liver inflammation C Xu, X Zhou, L Webb, S Yalavarthi, W Zheng, S Saha, R Schweickhardt, ... Cancer Immunology Research 12 (2), 195-213, 2024 | 1 | 2024 |
| Carbohydrate Mimetic Peptide Vaccines S Saha, A Pashov, B Monzavi-Karbassi, AM Kieber-Emmons, A Otaki, ... Anticarbohydrate Antibodies: From Molecular Basis to Clinical Application …, 2012 | 1 | 2012 |
| Developing Antibiotics with “Selfish DNA” Plasmids A Rao, S Saha Journal of Post-doctoral Research 5 (5), 1-2, 2017 | | 2017 |
| Perspective: small molecules as players in targeted therapies S Saha Bioinformatics Review 3 (2), 2017 | | 2017 |
| Structural Approaches for Targeted Therapy: the complex world of tumor associated carbohydrate antigens in cancer S Saha Lambert Publishers, 2016 | | 2016 |
| The Microbe Story at ASM microbe 2016-Need for Microbiome Research S Saha Bioinformatics Review 2 (4), 2016 | | 2016 |
| Tumor Associated Carbohydrate Antigens in Targeted Therapy S Saha Journal of Post-doctoral Research 4 (5), 1-12, 2016 | | 2016 |
| Commensal Gut Microbes play an important role in shaping host physiology S Saha Journal of Bacteriology & Mycology: Open Access 1 (2), 1-3, 2015 | | 2015 |
| Structural approaches for targeted therapy S Saha University of Arkansas at Little Rock, 2013 | | 2013 |
Anastas PashovInstitute of Microbiology, Bulgarian Academy of Sciences, SofiaVerified email at microbio.bas.bg
